News
MONTCO Today on MSN7h
GSK Bets Big on ‘Game-Changing’ Liver Disease DrugGSK has announced a $1.2 billion deal to acquire efimosfermin alfa from Boston Pharmaceuticals, writes John George for the ...
Aiming to expand its hepatology portfolio, UK pharma major GSK (LSE: GSK) yesterday announced that it has entered into an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback